SCHEMBL31123647

SCHEMBL31123647

COC(=O)c1ccccc1CSc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.58
PTGDR2 Q9Y5Y4 1/20 0.54
LMNA P02545 2/20 0.54
ALDH1A1 P00352 2/20 0.54
PKM P14618 1/20 0.49
HIF1A Q16665 1/20 0.49
HSD17B10 Q99714 2/20 0.49
POLB P06746 1/20 0.49
PPARG P37231 2/20 0.48
PPARA Q07869 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
CXCR2 P25025 1/20 0.47
TSHR P16473 1/20 0.47
RAB9A P51151 2/20 0.47
CFTR P13569 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11274332 1.00 L3MBTL1 (0.58) L3MBTL1PTGDR2LMNAALDH1A1PKM
SCHEMBL25685760 0.88 CXCR2 (0.57) L3MBTL1PTGDR2LMNAALDH1A1HSD17B10
SCHEMBL4630498 0.87 PPARG (0.55) L3MBTL1PTGDR2LMNAALDH1A1PKM
SCHEMBL5438157 0.87 PPARG (0.49) L3MBTL1PTGDR2LMNAALDH1A1PKM
SCHEMBL28104330 0.87 L3MBTL1 (0.51) L3MBTL1PTGDR2LMNAALDH1A1PKM
SCHEMBL27547400 0.86 ALDH1A1 (0.50) L3MBTL1PTGDR2LMNAALDH1A1HSD17B10
SCHEMBL15143214 0.85 HSD17B10 (0.67) L3MBTL1PTGDR2LMNAALDH1A1PKM
SCHEMBL4631073 0.85 PPARG (0.51) L3MBTL1PTGDR2LMNAALDH1A1PKM
SCHEMBL24483928 0.84 ALDH1A1 (0.59) L3MBTL1LMNAALDH1A1HIF1AHSD17B10
SCHEMBL12554580 0.84 L3MBTL1 (0.52) L3MBTL1PTGDR2LMNAALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692092-A1 NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF Aliad Biopharma (KR) 2026-02-11 EP disclosed
WO-2024205377-A1 NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF 알리아드바이오파마 주식회사 2024-10-03 WO disclosed